1st Quarter - Report

AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION for AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION

Firm
Client
Income
—
Expenses
$20,600
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 S. 2852/H.R. 6378 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI) H.R. 880/S. 1022 - Mission Zero Act Good Samaritan Health Professionals Act Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) Alternative Payment Models (APM) Common Rule Breast Cancer Research Stamp reauthorization Medicare for All Prior Authorization National Trauma Systems Legislation Drug Pricing Measuring Surgical Quality Surprise/Unanticipated Billing Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioid Legislation

LobbyistCovered position, as disclosed
PATRICK BAILEY —
HANNAH CHARGIN New —
MATTHEW COFFRON —
MARK LUKASZEWSKI —
KRISTIN MCDONALD —
KATIE OEHMEN —
JUSTIN ROSEN —
CHRISTIAN SHALGIAN —
CARRIE ZLATOS —

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA)

Bills named: S. 1022 (116th), S. 2852 (116th), S. 668 (116th), H.R. 8 (116th), H.R. 207 (116th), H.R. 1041 (116th), H.R. 1418 (116th), S. 966 (116th), H.R. 1379 (116th), H.R. 880 (116th), H.R. 6378 (116th), H.R. 1730 (116th), S. 741 (116th), H.R. 1841 (116th)

Veterans VET

H.R. 880/S. 1022 - Mission Zero Act National Trauma System (Military-Civilian Trauma Care)

LobbyistCovered position, as disclosed
PATRICK BAILEY —
HANNAH CHARGIN New —
MATTHEW COFFRON —
MARK LUKASZEWSKI —
KRISTIN MCDONALD —
KATIE OEHMEN —
JUSTIN ROSEN —
CHRISTIAN SHALGIAN —
CARRIE ZLATOS —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 1022 (116th), H.R. 880 (116th)

Budget/Appropriations BUD

Cancer Research and Funding Opioid Legislation Firearms CDC Research Funding

Contacted: Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); SENATE; Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Medicare/Medicaid MMM

PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 S. 2852/H.R. 6378 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI) H.R. 880/S. 1022 - Mission Zero Act Good Samaritan Health Professionals Act Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) Alternative Payment Models (APM) Common Rule Breast Cancer Research Stamp reauthorization Medicare for All Prior Authorization National Trauma Systems Legislation Drug Pricing Measuring Surgical Quality Surprise/Unanticipated Billing Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioid Legislation

LobbyistCovered position, as disclosed
PATRICK BAILEY —
HANNAH CHARGIN New —
MATTHEW COFFRON —
MARK LUKASZEWSKI —
KRISTIN MCDONALD —
KATIE OEHMEN —
JUSTIN ROSEN —
CHRISTIAN SHALGIAN —
CARRIE ZLATOS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); SENATE

Bills named: S. 966 (116th), H.R. 8 (116th), H.R. 1730 (116th), S. 2852 (116th), H.R. 1841 (116th), H.R. 1041 (116th), S. 668 (116th), H.R. 880 (116th), H.R. 1379 (116th), H.R. 1418 (116th), H.R. 207 (116th), H.R. 6378 (116th), S. 1022 (116th), S. 741 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.